ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Efficacy and safety of senaparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer (FLAMES study): A randomized, double-blind, placebocontrolled, phase III trial

Wu, X.; Liu, J.; Wang, X.; Wang, J.; Wang, L.; Zhu, J.; Kong, B.; Fei, J.; Tang, Y.; Xia, B.; Liang, Z.; Wang, K.; Lin, Z.; Huang, Y.; Zheng, H.; Lin, A.; Jiang, K.; Wang, W.; Wang, X.; Lou, G.复旦大学; 广州医学院; 吉林大学; 山东大学; 哈尔滨医科大学; 厦门大学; 中山大学; 重庆大学; 中国科学院研究生院; 1
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2023-10DOI: 10.1016/j.annonc.2023.10.030
5阅读
引用收藏
分享
相关
加载中…
  • Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial
    Li, Ning; Zhu, Jianqing; Yin, Rutie; Wang, Jing; Pan, Lingya; Kong, Beihua; Zheng, Hong; Liu, Jihong; Wu, Xiaohua; Wang, Li; Huang, Yi; Wang, Ke; Zou, Dongling; Zhao, Hongqin; Wang, Chunyan; Lu, Weiguo; Lin, An; Lou, Ge; Li, Guiling; Qu, Pengpeng; Yang, Hongying; Zhen, Xiaoa; Hang, Wenzhao; Hou, Jianmei; Wu, Lingying被引 21
  • Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial
    Li, Ning; Zhu, Jianqing; Yin, Rutie; Wang, Jing; Pan, Lingya; Kong, Beihua; Zheng, Hong; Liu, Jihong; Wu, Xiaohua; Wang, Li; Huang, Yi; Wang, Ke; Zou, Dongling; Zhao, Hongqin; Wang, Chunyan; Lu, Weiguo; Lin, An; Lou, Ge; Li, Guiling; Qu, Pengpeng; Yang, Hongying; Zhen, Xiaoa; Hang, Wenzhao; Hou, Jianmei; Banerjee, Ashish; Wu, Lingying
  • SABRINA study: A phase II study of senaparib monotherapy for patients (pts) with BRCA1/2 mutated recurrent platinum-sensitive ovarian cancer (PSOC)
    Wu, X.; Liu, J.; Wang, L.; Lin, Z.; Wang, J.; Wang, C.; Kong, B.; Liang, Z.; Cheng, Y.; Wen, H.; Lou, G.; Huang, Y.; Wang, K.; An, R.; Zhu, J.; Zhou, H.; Yue, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2023-10-20 至 2023-10-24
论文集名
ANNALS OF ONCOLOGY
发表日期
2023-10
起止页码
S1277-S1278
DOI
10.1016/j.annonc.2023.10.030
资助标注
IMPACT Therapeutics, Inc.
收录
ISTP · SCIE

作者

  • W

    Wu, X. (第一作者)

    fudan univ

  • L

    Liu, J.

    sun yat sen univ

查看全部 20 位作者收起作者
  • W

    Wang, X.

  • W

    Wang, J.

    hunan canc hosp

  • W

    Wang, L.

  • Z

    Zhu, J.

    univ chinese acad sci · zhejiang canc hosp

  • K

    Kong, B.

    shandong univ

  • F

    Fei, J.

    jilin univ

  • T

    Tang, Y.

    chongqing univ

  • X

    Xia, B.

    anhui prov hosp

  • L

    Liang, Z.

  • W

    Wang, K.

    tianjin med univ canc inst & hosp

  • L

    Lin, Z.

  • H

    Huang, Y.

    hubei canc hosp

  • Z

    Zheng, H.

  • L

    Lin, A.

    fujian prov canc hosp

  • J

    Jiang, K.

    2 · dalian med univ

  • W

    Wang, W.

    1 · guangzhou med univ

  • W

    Wang, X.

  • L

    Lou, G.

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417